[1]刘海英,桂晓凤,姜家英.CD24、β-连环蛋白在卵巢癌及癌前病变患者组织中的表达及临床意义[J].陕西医学杂志,2023,52(1):101-104.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.024]
　LIU Haiying,GUI Xiaofeng,JIANG Jiaying.Clinical study of CD24 and β-catenin expression in ovarian cancer and premalignant lesions[J].,2023,52(1):101-104.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.024]
点击复制

CD24、β-连环蛋白在卵巢癌及癌前病变患者组织中的表达及临床意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年1期
页码:
101-104
栏目:
临床病理
出版日期:
2023-01-05

文章信息/Info

Title:
Clinical study of CD24 and β-catenin expression in ovarian cancer and premalignant lesions
作者:
刘海英; 桂晓凤; 姜家英
(安康市中医医院产科,陕西 安康725000)
Author(s):
LIU Haiying; GUI Xiaofeng; JIANG Jiaying
(Department of Obstetrics,Ankang Hospital of Traditional Chinese Medicine,Ankang 725000,China)
关键词:
CD24;  β-连环蛋白;  免疫球蛋白样凝集素-10;  卵巢癌;  癌前病变;  临床特征
Keywords:
CD24;  Beta-catenin;  Siglec-10;  Ovarian cancer;  Precancerous lesion;  Clinical feature
分类号:
R 737.31
DOI:
DOI:10.3969/j.issn.1000-7377.2023.01.024
文献标志码:
A
摘要:
目的:探究卵巢癌及癌前病变患者组织标本中CD24、β-连环蛋白(β-catenin)的表达状况及其与患者临床特征的关联性。方法:选取就诊并进行治疗的40例良性卵巢肿瘤患者(A组),40例交界性卵巢肿瘤患者(B组),60例卵巢癌患者(C组),同期60例体检健康的女性患者(N组)为研究对象。观察CD24、β-catenin与相关蛋白唾液酸结合免疫球蛋白样凝集素-10(Siglec-10)、Engrailed-2(EN2)在各组研究对象组织中的表达情况,同时分析CD24、β-catenin表达与卵巢癌患者临床特征间的关联性; 并对 CD24与Siglec-10、β-catenin与EN2表达的相关性进行分析。结果:A组、B组、C组、N组四组研究对象中,CD24阳性表达率分别为22.50%、57.50%、85.00%、6.67%; β-catenin阳性表达率分别为27.50%、67.50%、81.67%、10.00%; Siglec-10阳性表达率分别为25.00%、65.00%、88.33%、8.33%,EN2阳性表达率分别为35.00%、62.50%、78.33%、10.00%,且组间比较差异有统计学意义(均P<0.05)。在卵巢癌患者组织中,CD24、β-catenin表达与患者年龄、病理类型不存在显著关联(均P>0.05),CD24表达与患者临床分期、淋巴结转移、组织分化均存在显著关联(均P<0.05),β-catenin表达与患者组织分化存在显著相关性(P<0.05),且CD24与Siglec-10、β-catenin与EN2 表达均呈现正相关性(r=0.865,r=0.901,均P=0.000)。结论:对于卵巢癌患者而言,随着患者病变程度的加深,CD24、β-catenin的表达呈现上调趋势,CD24相关蛋白Siglec-10、EN2的表达也呈现上调趋势; 同时CD24的表达与患者临床分期、组织分化及淋巴结转移均存在显著关联,β-catenin的表达与患者组织分化存在显著关联。此外,卵巢癌患者组织中CD24与Siglec-10、β-catenin与EN2 表达均呈现正相关性,为临床诊疗提供了参考价值。
Abstract:
Objective:To explore the expression status of CD24 and β-catenin in tissue samples of patients with ovarian cancer and precancerous lesions and their correlation with clinical characteristics of patients.Methods:Forty patients with benign ovarian tumors(group A),Forty patients with cross-sectional ovarian tumors(group B),sixty patients with ovarian cancer(group C),and sixty healthy women(group N)were included in the study.The expressions of CD24,β-catenin and related proteins Siglec-10 and EN2 in the tissues of the subjects in each group were observed.The correlation between the expressions of CD24,β-catenin and the clinical characteristics of ovarian cancer patients was analyzed.The correlation between the expressions of CD24,Siglec-10,β-catenin and EN2 was also analyzed.Results:In groups A,B,C and N,the positive expression rates of CD24 were 22.50%,57.50%,85.00% and 6.67%,respectively; the positive expression rates of β-catenin were 27.50%,67.50%,81.67% and 10.00%,respectively; the positive expression rates of Siglec-10 were 25.00%,65.00%,88.33% and 8.33%,respectively; the positive expression rates of EN2 were 35.00%,62.50%,78.33% and 10.00%,respectively,with significant differences between groups(all P<0.05).In the tissues of patients with ovarian cancer,the expressions of CD24 and β-catenin was not significantly correlated with the patient's age and pathological type(all P>0.05),but the expression of CD24 was significantly correlated with the clinical stage,lymph node metastasis and tissue differentiation(all P<0.05),and the expression of β-catenin was significantly correlated with the tissue differentiation(P<0.05),and the expressions of CD24 and Siglec-10,and the expressions of β-catenin and EN2 were all positively correlated(r=0.865,r=0.901,all P=0.000).Conclusion:For ovarian cancer patients,with the deepening of the lesion,the expressions of CD24 and β-catenin were up-regulated,related proteins Siglec-10 and EN2 were also up-regulated.The expression of CD24 was significantly correlated with the clinical stage,tissue differentiation and lymph node metastasis,and the expression of β-catenin was significantly correlated with the tissue differentiation.In addition,the expressions of CD24 and Siglec-10,the expressions of β-catenin and EN2 in the tissues of ovarian cancer patients were positively correlated,which provided a reference value for clinical diagnosis and treatment.

参考文献/References:

[1] 关慧鑫,韩世愈.卵巢癌肿瘤干细胞及其标志物与卵巢癌靶向治疗的研究进展[J].中国生育健康杂志,2022,33(1):90-93,97.
[2] 朱军义,马繁华,徐亚辉.龙葵碱调控p-AKT、Cleaved caspase-3和p53蛋白表达抑制卵巢癌细胞增殖实验研究[J].陕西中医,2019,40(5):556-560.
[3] 王 琰,陆 鹤,王 静.外周血间皮素、人附睾蛋白4检测对卵巢上皮性癌临床分期及淋巴转移的预测价值[J].陕西医学杂志,2020,49(8):1045-1048.
[4] 李成斐,朱 萍,于 佳,等.益气活血解毒方联合化疗治疗晚期卵巢癌疗效及对患者免疫通路相关靶基因的影响[J].陕西中医,2021,42(8):1072-1075,1079.
[5] 高 燕,杨 红,刘淑娟,等.线粒体动态蛋白在卵巢癌中的表达及临床意义[J].陕西医学杂志,2021,50(12):1589-1593.
[6] 王沈峰,金 迎,周禄荣,等.益气活血法治疗卵巢癌及对患者血清人附睾蛋白4、间皮素及肿瘤标记物的影响研究[J].陕西中医,2020,41(5):646-649.
[7] 李 颖,蓝 婷,王 悦,等.sEGFR、RDW与CA125联合检测在卵巢癌中的诊断价值[J].检验医学与临床,2022,19(16):2161-2164.
[8] 耿海慧,曹爱华.卵巢癌患者多种血清肿瘤标志物表达水平及其对疾病的诊断价值研究[J].陕西医学杂志,2022,51(7):886-889.
[9] 陈 姝,张 競,李燕华.CD24和Siglec-10在上皮性卵巢癌组织中的表达及意义[J].中华全科医学,2021,19(3):428-431.
[10] 高俊彦.miR-139-5p通过调节Wnt/β-catenin信号通路在卵巢癌中发挥抑癌作用[J].现代肿瘤医学,2022,30(11):1920-1924.
[11] 宋 晨,王春莲,赵丽荣,等.EN2及β-catenin在卵巢癌组织中的表达及临床意义[J].医学研究杂志,2020,49(5):76-79.
[12] 衡燕春,马珊珊,马 玲.调节性B细胞在卵巢癌病人外周血中表达及其临床意义[J].蚌埠医学院学报,2021,46(6):767-770,774.
[13] 沈艳丽,冯文广,易金玲.GOLPH3及PI3K在卵巢癌组织中的表达及意义[J].分子诊断与治疗杂志,2022,14(8):1342-1345.
[14] 赵 爽,孔 丹.CD24蛋白与卵巢癌相关性的研究进展[J].现代肿瘤医学,2022,30(7):1332-1336.
[15] 刘鑫路,吴运萍,张林海,等.卵巢上皮癌CD24和Yes相关蛋白1的表达及其临床意义[J].成都医学院学报,2021,16(5):636-639,644.
[16] 黎超莲,邹嘉雯,李荣威,等.HOXA5、E-cadherin、β-catenin在卵巢癌组织中的表达[J].安徽医科大学学报,2019,54(7):1092-1096.
[17] 李 琳,叶丽平.YAP和β-catenin在卵巢癌中的表达及临床意义[J].锦州医科大学学报,2020,41(6):41-45.
[18] 刘卫民,柳学芳,龚文端.miRNA-27a靶向SPRY2调控Wnt/β-catenin信号通路对人卵巢癌细胞增殖和侵袭能力的影响[J].癌症进展,2018,16(3):282-285.
[19] 梁运霞,张玉文,秦珍珠,等.STAT2、CD24和CD44在卵巢癌组织中的表达及其与卵巢癌临床病理特征的关系[J].中国组织化学与细胞化学杂志,2021,30(4):354-358.
[20] 王 佳,程子芸,赵 娟,等.卵巢癌组织中CXCR4表达的临床意义及与β-catenin的相关性分析[J].山西医科大学学报,2019,50(8):1088-1092.

相似文献/References:

[1]朱 静,梁健球,刘宝骅.川芎嗪调控Wnt/β-连环蛋白信号通路对冠心病大鼠心肌细胞凋亡的机制研究[J].陕西医学杂志,2024,(1):13.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.003]
　ZHU Jing,LIANG Jianqiu,LIU Baohua.Mechanism of tetramethylpyrazine regulating Wnt/β-catenin signaling pathway on cardiomyocyte apoptosis in rats with coronary heart disease[J].,2024,(1):13.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.003]
[2]徐 霞,张 红,王鹏程,等.他莫昔芬联合左炔诺孕酮对大鼠子宫肌瘤的影响及机制研究[J].陕西医学杂志,2024,(5):589.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.003]
　XU Xia,ZHANG Hong,WANG Pengcheng,et al.Effects of tamoxifen combined with levonorgestrel on uterine fibroids in rats and their mechanism[J].,2024,(1):589.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.003]

备注/Memo

备注/Memo:
基金项目:陕西省自然科学基金资助项目(2016JM8099)
更新日期/Last Update: 2022-12-28